Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlled Release Pregabalin in Fibromyalgia
NCT01271933Phase 3Completed
- Sponsor
- Viatris
- Start
- Mar 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Pregabalin with Placebo (2 arms). Primary endpoints: Time to Loss of Therapeutic Response (LTR) at Week 19 and Number of Participants With Loss of Therapeutic Response (LTR) Event at Week 19. Started Mar 2011; status: completed.
02
Drugs
pregabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01271933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271933.